Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Zeneca describes nonpeptide antagonists of NK2 receptors

Jan. 8, 1997

Improved formulation of Vanceril approved for market

Jan. 7, 1997

Genome Therapeutics and Schering-Plough genomic-based collaboration

Dec. 31, 1996

Heterocyclic tachykinin antagonists revealed by Zeneca

Dec. 31, 1996

New NK1 antagonists from Ciba-Geigy

Dec. 31, 1996

Dual-action compounds with antiasthma activity reported by Kowa

Dec. 30, 1996

Novel antihistamine formulation approved by FDA

Dec. 24, 1996

LIDAK develops drug discovery approach for asthma

Dec. 23, 1996

Boehringer Ingelheim's modified anti-ICAM-1 antibodies for inflammatory disorders

Dec. 23, 1996

Cortech regains rights to elastase inhibitor

Dec. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...